WallStreetZenWallStreetZen

NASDAQ: LHCG
Lhc Group Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for LHCG

Based on 8 analysts offering 12 month price targets for Lhc Group Inc.
Min Forecast
$150.00-8.83%
Avg Forecast
$170.38+3.56%
Max Forecast
$191.00+16.1%

Should I buy or sell LHCG stock?

Based on 10 analysts offering ratings for Lhc Group Inc.
Hold
Strong Buy
0 analysts 0%
Buy
3 analysts 30%
Hold
7 analysts 70%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LHCG stock forecasts and price targets.

LHCG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Deutsche Bank
Bottom 27%
27
HoldDowngrades$170.00+3.33%2022-04-25
Anonymous
Barclays
HoldMaintains$170.00+3.33%2022-04-12
RBC Capital
Bottom 11%
11
HoldDowngrades$170.00+3.33%2022-04-04
Truist Securities
Top 10%
91
HoldDowngradesN/AN/A2022-03-31
Benchmark
Top 5%
96
HoldDowngradesN/AN/A2022-03-30
Credit Suisse
Top 5%
96
HoldDowngrades$170.00+3.33%2022-03-30
Credit Suisse
Top 24%
77
BuyMaintains$181.00+10.02%2022-02-28
SVB Leerink
Bottom 20%
20
HoldMaintains$151.00-8.22%2021-11-10
RBC Capital
Bottom 5%
5
BuyMaintains$180.00+9.41%2021-11-05
Cowen & Co.
Bottom 16%
16
HoldDowngrades$150.00-8.83%2021-10-26

1 of 2

Forecast return on equity

Is LHCG forecast to generate an efficient return?
Company
16.45%
Industry
-75.76%
Market
118.31%
LHCG's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LHCG forecast to generate an efficient return on assets?
Company
8.83%
Industry
8.78%
LHCG is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LHCG earnings per share forecast

What is LHCG's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$5.08+113.45%
Avg 2 year Forecast
$5.79+143.28%
Avg 3 year Forecast
$6.64+178.99%
LHCG's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

LHCG revenue forecast

What is LHCG's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$2.4B+5.62%
Avg 2 year Forecast
$2.6B+14.14%
Avg 3 year Forecast
$2.9B+24.97%
LHCG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LHCG earnings growth forecast

How is LHCG forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
40.49%
Industry
4.54%
Market
16.45%
LHCG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
LHCG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
LHCG's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

LHCG revenue growth forecast

How is LHCG forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
7.54%
Industry
8.88%
Market
8.47%
LHCG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LHCG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LHCG vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
LHCG$164.52$170.38+3.56%Hold
OPCH$29.77$38.50+29.32%Strong Buy
THC$50.67$97.71+92.83%Strong Buy
EHC$46.96$70.50+50.13%Strong Buy
AMN$103.11$136.60+32.48%Strong Buy
View Top Medical Care Facility Stocks

Lhc Group Stock Forecast FAQ

Is Lhc Group Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: LHCG) stock is to Hold LHCG stock.

Out of 10 analysts, 0 (0%) are recommending LHCG as a Strong Buy, 3 (30%) are recommending LHCG as a Buy, 7 (70%) are recommending LHCG as a Hold, 0 (0%) are recommending LHCG as a Sell, and 0 (0%) are recommending LHCG as a Strong Sell.

If you're new to stock investing, here's how to buy Lhc Group stock.

What is LHCG's earnings growth forecast for 2022-2024?

(NASDAQ: LHCG) Lhc Group's forecast annual earnings growth rate of 40.49% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 4.54%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 16.45%.

Lhc Group's earnings in 2022 is $73,464,000.On average, 8 Wall Street analysts forecast LHCG's earnings for 2022 to be $157,626,416, with the lowest LHCG earnings forecast at $127,838,747, and the highest LHCG earnings forecast at $179,967,168. On average, 8 Wall Street analysts forecast LHCG's earnings for 2023 to be $179,656,879, with the lowest LHCG earnings forecast at $138,078,258, and the highest LHCG earnings forecast at $212,857,719.

In 2024, LHCG is forecast to generate $206,031,378 in earnings, with the lowest earnings forecast at $161,970,451 and the highest earnings forecast at $238,301,353.

What is LHCG's revenue growth forecast for 2022-2024?

(NASDAQ: LHCG) Lhc Group's forecast annual revenue growth rate of 7.54% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 8.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.47%.

Lhc Group's revenue in 2022 is $2,296,568,000.On average, 7 Wall Street analysts forecast LHCG's revenue for 2022 to be $75,265,682,661, with the lowest LHCG revenue forecast at $73,277,666,035, and the highest LHCG revenue forecast at $77,327,237,594. On average, 7 Wall Street analysts forecast LHCG's revenue for 2023 to be $81,334,423,783, with the lowest LHCG revenue forecast at $78,581,112,291, and the highest LHCG revenue forecast at $84,936,435,613.

In 2024, LHCG is forecast to generate $89,052,160,621 in revenue, with the lowest revenue forecast at $85,763,974,296 and the highest revenue forecast at $91,957,947,744.

What is LHCG's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: LHCG) forecast ROA is 8.83%, which is higher than the forecast US Medical Care Facilities industry average of 8.78%.

What is LHCG's Price Target?

According to 8 Wall Street analysts that have issued a 1 year LHCG price target, the average LHCG price target is $170.38, with the highest LHCG stock price forecast at $191.00 and the lowest LHCG stock price forecast at $150.00.

On average, Wall Street analysts predict that Lhc Group's share price could reach $170.38 by Apr 25, 2023. The average Lhc Group stock price prediction forecasts a potential upside of 3.56% from the current LHCG share price of $164.52.

What is LHCG's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: LHCG) Lhc Group's current Earnings Per Share (EPS) is $2.38. On average, analysts forecast that LHCG's EPS will be $5.08 for 2022, with the lowest EPS forecast at $4.12, and the highest EPS forecast at $5.80. On average, analysts forecast that LHCG's EPS will be $5.79 for 2023, with the lowest EPS forecast at $4.45, and the highest EPS forecast at $6.86. In 2024, LHCG's EPS is forecast to hit $6.64 (min: $5.22, max: $7.68).

What is LHCG's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: LHCG) forecast ROE is 16.45%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.